Skip to Content
Merck
  • Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy.

Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology (2010-10-28)
Mateusz Kwitniewski, Johan Moan, Asta Juzeniene
ABSTRACT

For the first time we present data showing that metabolic targeted therapy with dichloroacetate (DCA) may improve the outcome of photodynamic therapy. This treatment modality can be easily introduced into clinical practice guidelines.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-Aminoisophthalic acid, 94%